.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Identify first generic entrants
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
AstraZeneca
Federal Trade Commission
Boehringer Ingelheim
Johnson and Johnson
QuintilesIMS
Deloitte
Farmers Insurance
Baxter
Cipla

Generated: June 22, 2017

DrugPatentWatch Database Preview

FLUMADINE Drug Profile

« Back to Dashboard

What is the patent landscape for Flumadine, and when can generic versions of Flumadine launch?

Flumadine is a drug marketed by Caraco and Forest Labs and is included in two NDAs.

The generic ingredient in FLUMADINE is rimantadine hydrochloride. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the rimantadine hydrochloride profile page.

Summary for Tradename: FLUMADINE

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list82
Patent Applications: see list683
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLUMADINE at DailyMed

Pharmacology for Tradename: FLUMADINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Caraco
FLUMADINE
rimantadine hydrochloride
TABLET;ORAL019649-001Sep 17, 1993ABRXYesYes► Subscribe► Subscribe
Forest Labs
FLUMADINE
rimantadine hydrochloride
SYRUP;ORAL019650-001Sep 17, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Cerilliant
Farmers Insurance
Citi
Fuji
Queensland Health
McKinsey
Medtronic
McKesson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot